<?xml version="1.0" encoding="UTF-8"?>
<p>Limited vaccine effectiveness constitutes another barrier in the fight against HBV. Thus, 2 of our patients became infected despite prior vaccination, 1 of whom was HIV-positive. As HIV infection is not only a well-recognized risk factor for poorer response to the HBV vaccine but also for developing chronic infection, including tenofovir as part of the HIV treatment can confer additional protection [
 <xref rid="CIT0010" ref-type="bibr">10</xref>, 
 <xref rid="CIT0011" ref-type="bibr">11</xref>].
</p>
